Market Value181,109,000
Total Holdings56
File Date2015-11-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BMY / Bristol-Myers Squibb Company
AGIO / Agios Pharmaceuticals, Inc.
SGEN / Seagen Inc
ALNY / Alnylam Pharmaceuticals, Inc.
ISEE / IVERIC bio Inc
MRK / Merck & Co., Inc.
ALBO / Albireo Pharma Inc
MACK / Merrimack Pharmaceuticals, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
CLVS / Clovis Oncology Inc
MDVN / Medivation, Inc.
HOLX / Hologic, Inc.
NVAX / Novavax, Inc. Call
NVAX / Novavax, Inc. Put
SIOX / Sio Gene Therapies Inc.
HGEN / Humanigen, Inc.
PCRX / Pacira BioSciences, Inc.
XNPT / XenoPort, Inc.
76028H209 / Repros Therapeutics, Inc. Call
US00448Q2012 / Achillion Pharmaceuticals, Inc.
/ Array BioPharma, Inc. Call
JUNO / Juno Therapeutics, Inc.
ARROWHEAD RESH CORP / (042797209)
JUNO / Juno Therapeutics, Inc. Put
DIREXION SHS ETF TR / (25490K752)
NSTG / NanoString Technologies, Inc.
VCEL / Vericel Corporation
OCRX / Ocera Therapeutics, Inc.
/ Array BioPharma, Inc.
CPHD / Cepheid
RLYP / Relypsa, Inc.
CRIS / Curis, Inc.
NEPT / Neptune Wellness Solutions Inc.
STML / Stemline Therapeutics, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
US6363752063 / National Holdings Corp.
FLDM / Standard BioTools Inc
AVDL / Avadel Pharmaceuticals plc
BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology
RCPT / Receptos, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
ACRX / Talphera, Inc.
ASMB / Assembly Biosciences, Inc.
INFI / Infinity Pharmaceuticals Inc.
INCY / Incyte Corporation
KPTI / Karyopharm Therapeutics Inc.
CMRX / Chimerix, Inc.
GILD / Gilead Sciences, Inc.
ESPR / Esperion Therapeutics, Inc.
TSRO / TESARO, Inc.
ZGNX / Zogenix Inc
VRTX / Vertex Pharmaceuticals Incorporated
BMRN / BioMarin Pharmaceutical Inc.
NKTR / Nektar Therapeutics
CELG / Celgene Corp.
RARE / Ultragenyx Pharmaceutical Inc.
IONS / Ionis Pharmaceuticals, Inc.
BIIB / Biogen Inc.
TECH / Bio-Techne Corporation
ALKS / Alkermes plc
UTHR / United Therapeutics Corporation
EPZM / Epizyme Inc
IBB / iShares Trust - iShares Biotechnology ETF
AMGN / Amgen Inc.
ILMN / Illumina, Inc.
MTD / Mettler-Toledo International Inc.
QGEN / Qiagen N.V.
REGN / Regeneron Pharmaceuticals, Inc.